| |
Express Scripts Financial Highlights for 1997
| (in thousands, except per share data) |
1997 |
1996 |
% Change |
| Income Statement Data: |
|
|
|
| Net Revenue |
$ 1,230,634 |
$ 773,615 |
59% |
| Pretax Income |
54,706 |
43,080 |
27% |
| Net Income |
33,429 |
26,148 |
28% |
| Per Share Data: |
|
|
|
| Net Income |
$ 2.02 |
$ 1.60 |
26% |
| Stockholders' Equity |
$ 12.30 |
$ 10.04 |
23% |
| Balance Sheet Data: |
|
|
|
| Total Current Assets |
$ 363,968 |
$ 263,149 |
38% |
| Total Assets |
402,508 |
300,425 |
34% |
| Total Debt |
- |
- |
- |
| Working Capital |
166,062 |
128,259 |
29% |
| Stockholders' Equity |
203,701 |
164,090 |
24% |
| Average Shares Outstanding: |
16,561 |
16,350 |
1.3% |
|
|
| |
Forward Looking Statements
Information included in this Annual Report and releases issued or statements made by the Company contain or may contain forward-looking statements, including but not limited to statements of the Company's plans, objectives, expectations or intentions. Such forward-looking statements necessarily involve risks and uncertainties. The Company's actual results may differ significantly from those projected or suggested in the forward-looking statements. Factors that might cause such a difference to occur include, but are not limited to: heightened competition, including increased price competition in the pharmacy benefit management market; the possible termination of the Company's contracts with certain key clients; changes in pricing, discount or rebate practices of pharmaceutical manufacturers; the ability of the Company to consummate contract negotiations with prospective clients; competition in the bidding and proposal process; adverse results in certain litigation and regulatory matters; the adoption of adverse legislation or regulations or a change in the interpretation of existing legislation or regulations; risks associated with acquisitions, including difficulties in integrating the acquired companies; and other risks described from time to time in the Company's filings with the Securities and Exchange Commission.
|
|